Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2010
04/28/2010CN1548039B Red sage dripping pill and its preparation
04/28/2010CN1525852B Granules and granules coated with a masked taste
04/28/2010CN1524579B Composite viscoelastic preparation
04/28/2010CN1524517B Oral medicament composition containing non-steroid antiphlogistic drugs and its preparation method
04/28/2010CN1496271B Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases
04/28/2010CN1444948B Liposome of Breviscapine and its preparing method
04/28/2010CN1434043B Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
04/28/2010CN1416335B New self emulsifying drug delivery system
04/28/2010CN101698684A Method for extracting polysaccharose from ginseng and application
04/28/2010CN101698673A Prawn white spot syndrome virus VP37p polypeptide fragment and application thereof
04/28/2010CN101698668A Crystal form V of Aildenafil citrate and preparation method and application thereof
04/28/2010CN101698651A Salicylanilide derivatives, preparation method thereof and application thereof
04/28/2010CN101698649A Short-acting hypnotizing and calming compound used for anesthetization
04/28/2010CN101698103A Medicine composite for treating B type diabetes
04/28/2010CN101698101A Medicine composite for treating vaginitis
04/28/2010CN101698096A Plaster for treating white vein diseases and preparation method thereof
04/28/2010CN101698095A Drug composition liniment or lotion for treating white vein diseases and preparation method thereof
04/28/2010CN101698094A Distillate for treating white vein diseases and preparation method thereof
04/28/2010CN101698093A Drug composition oral preparation used for relaxing tendons and activating collaterals and preparation method thereof
04/28/2010CN101698090A Traditional Chinese medicine composite for treating coma and heart syncope symptoms and preparation method thereof
04/28/2010CN101698088A Traditional Chinese medicine for treating hyperblastosis of human body
04/28/2010CN101698077A Healthy carry-on bag
04/28/2010CN101698055A Traditional Chinese medicine medicated wine
04/28/2010CN101698048A Traditional Chinese medicine ointment for treating high blood pressure and preparation method thereof
04/28/2010CN101698046A Lozenge for diminishing inflammation and clearing pharynx
04/28/2010CN101698041A Aloe vitamin C effervescent tablet
04/28/2010CN101698038A Paster for treating cancer pain and preparation method thereof
04/28/2010CN101698036A Traditional Chinese medicine for treating haemorrhoids, traditional Chinese medicine cataplasm and preparation method thereof
04/28/2010CN101698035A Method for preparing anti-tumor active ingredients of Chinese fan palm
04/28/2010CN101698033A Big plaster for treating various rheumatic osteopathy and traumatic injuries
04/28/2010CN101698018A Traditional Chinese medicine composite for treating gynecologic diseases and preparation method thereof
04/28/2010CN101698017A Antiphlogosis and sterilizing ointment
04/28/2010CN101698009A Externally-applied medicament for treating skin diseases
04/28/2010CN101698007A Medicine for treating aphtha
04/28/2010CN101697998A Zhenhuang tablet for treating sore throat and ulcer and sore furuncle and preparation method thereof
04/28/2010CN101697997A External cool refreshing liquid
04/28/2010CN101697995A Medicine for treating gastrosis
04/28/2010CN101697994A Radiation-resistant and fatigue-resistant agent and preparation method thereof
04/28/2010CN101697989A Application of notoginseng and extract thereof in preparing medicaments for treating and/or preventing coronary artherosclerosis
04/28/2010CN101697975A GSLS tablets used for animals and poultries and preparation method thereof
04/28/2010CN101697974A GSLS capsules used for animals and poultries and preparation method thereof
04/28/2010CN101697973A Cefathiamidine preparation for injection and preparation method thereof
04/28/2010CN101697972A Application of neoaspergillic acid in preparing antitumor drugs
04/28/2010CN101697971A Rehabilitation therapy method for lung cancer
04/28/2010CN101697970A Medicine composite for treating and relieving high blood pressure
04/28/2010CN101697969A Ornidazole medicinal composition and preparation method thereof
04/28/2010CN101697968A Melatonin capsule
04/28/2010CN101697967A Adapalene-vitamin E compound cream and preparation method thereof
04/28/2010CN101697966A Application of furanodiene in preparation of medicaments for treating diseases caused by viruses
04/28/2010CN101697965A Inhalation capsules
04/28/2010CN101697964A Combretaftation A-4P frozen preparation and preparation method thereof
04/28/2010CN101697963A Method for preparing PLGA slow-release microsphere carrying docetaxel and application thereof in chemotherapy of mesenchyma stroma of tumors under ultrasonic mediation
04/28/2010CN101697962A Process for preparing matrine-loaded magnetic chitosan microspheres
04/28/2010CN101697961A New cefmenoxime hydrochloride preparation for drug administration by injection and preparation method thereof
04/28/2010CN101697960A Huperzine-A solid dispersion and method for preparing tablet thereof
04/28/2010CN101697959A Potassium sodium dehydroandrographolide succinate and sodium chloride injection and preparation method thereof
04/28/2010CN101697958A Standard dose traditional Chinese medicine decocted extract and preparation method thereof
04/28/2010CN101229160B Antihypertensive medicine containing amlodipine besylate
04/28/2010CN101014560B Wikstroemia indeca extract, their production and use in the production of anti-inflammatory pharmaceutical
04/27/2010USRE41289 Ultrashort acting hypnotic barbiturates
04/27/2010USRE41288 increasing insulinotropic response in ischemia and treating reperfusion and injured brain cells after an ischemic event by administering glucagon-like peptide-1 and a pharmaceutical carrier for a time sufficient and under conditions effective to increase insulinotropic response which produces insulin
04/27/2010USRE41279 made by combining aqueous composition containing visual indicator and organic components and aqueous solution of salt of chlorous acid, preferably alkali metal chlorite; materials are blended into viscous material containing emollient package which generates active antimicrobial chlorine dioxide
04/27/2010USRE41278 useful to alleviate or improve various cosmetic conditions and dermatological disorders, including changes or damage to skin, nail and hair associated with intrinsic aging and/or extrinsic aging, as well as changes or damage caused by extrinsic factors
04/27/2010US7705195 Screening method
04/27/2010US7705191 Sedatives; oxidation resistance; nervous system disorders
04/27/2010US7705188 protecting 3,5-DIhydroxybenzaldehyde with diisopropylethylamine/N,N-/ and silyl chloride, reacting 3,5-di(tert-butyldimethylsilyloxy)-benzaldehyde product with 4-methoxybenzyltriphenylphosphonium bromide to obtain 3,5-di(tert-butyldimethylsilyloxy)-4'-methoxy-stilbene, deprotecting and separating
04/27/2010US7705185 alkylating 3,5-bis(1,1-dimethylethyl)-4-hydroxy-N-(4-hydroxy)-benzenepropanamide with decyl bromide in presence of acetone solvent to form alkylated product; better thermal stability
04/27/2010US7705182 Multi-substituted selective androgen receptor modulators and methods of use thereof
04/27/2010US7705168 Manufacturing process for tigecycline
04/27/2010US7705164 Metalloprotein inhibitors
04/27/2010US7705158 Inhibitors of ion channels
04/27/2010US7705156 Heteroaryl (substituted)alkyl N-substituted sulfoximines as insecticides
04/27/2010US7705153 chemokine coupled receptor 3 (CCR3); treating asthma; 1-(heteroarylcarbonyl)-4-piperidino-piperidine compounds
04/27/2010US7705149 Benzoimidazole compounds
04/27/2010US7705148 substituted diaminopyrimidine compounds having HIV inhibiting properties; reacting 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine with an intermediate (4-cyano, 2-pyrimidine- aniline derivative; reaction with acrylonitril
04/27/2010US7705147 e.g.2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-(pyrimidine or pyridazine or piperazine)-pyrrole-5-carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive
04/27/2010US7705146 inhibitors of the hepatitis C virus NS3 protease; azalactone intermediate reacted with amide anion and decylization; urea or carbamate-terminated alkylglycine, hydroxyproline, cyclopropylglycine tripeptide
04/27/2010US7705143 Benzoimidazole compounds
04/27/2010US7705135 plant extracts; homogenizing; high molecular weight and low degree of methylation; controlled release
04/27/2010US7705129 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
04/27/2010US7705055 Treating neurological disorders using selective antagonists of persistent sodium current
04/27/2010US7705054 Method of preventing and/or treating oxidant injury in neurodegenerative and oxidative diseases
04/27/2010US7705053 Benzamide derivative
04/27/2010US7705052 Sulfonamide derivatives for the treatment of diabetes
04/27/2010US7705051 Therapeutical agent useful for the treatment of plasma cell neoplasias
04/27/2010US7705050 Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils
04/27/2010US7705049 Methods for treating non-melanoma cancers with PABA
04/27/2010US7705048 Animal growth regulator; infants
04/27/2010US7705047 N-[1-cyano-1-methyl-2-(5-cyano-2-{2,4-dichlorophenoxy}-phenoxy)-ethyl]-4-trifluoromethoxybenzamide; etherification with a cyano-halobenzene in the presence of a basic catalyst; parasiticides, especially antihelmintics; veterinary medicine
04/27/2010US7705046 two new crystalline forms, delta and epsilon, of perindopril erbumine; suitable as therapeutic active substances for medicaments for the treatment of cardio-vascular diseases, especially high blood pressure and heart failure
04/27/2010US7705045 compounds comprising a specifier linked to two or more of the same or different leaving groups via a self-eliminating multiple release spacer or spacer system, which compounds upon a single activation step, in particular removal or transformation of the specifier, release two or more leaving groups
04/27/2010US7705044 Benzamidoacetonitriles and their use as antiparasitics
04/27/2010US7705043 Methyl 4-{[(2-{4-[(4-bromophenoxy)methyl]-2,5-dimethyl-3-thienyl}ethyl)(5-ethoxy-5-oxopentyl)amino]methyl}benzoate, for example; treatment of cardiovascular and other diseases
04/27/2010US7705042 Class of arylamide compounds useful as inhibitors of c-fms kinase
04/27/2010US7705040 Reagents for highly specific detection of peroxynitrite
04/27/2010US7705039 Method for treating sleep apnea
04/27/2010US7705038 treating and/or preventing (including metaphylaxis) ecto- and/or endoparasite infestations of animals, as well as methods of killing, inhibiting and/or suppressing growth of such parasites by contacting parasites with compounds such as 2-(3,4-methylenedioxy)phenyl-3-(1H-pyrrol-2-yl)acrylonitrile
04/27/2010US7705036 used in studies of metabolism of drugs and toxic substances in humans and other animals; deuterated compounds are used in pharmaceutical research to investigate in vivo metabolic fate of compounds by evaluation of mechanism of action and metabolic-pathway of non deuterated parent compound; drug design
04/27/2010US7705035 Indoline amide derivatives as EP4 receptor ligands
04/27/2010US7705034 Vinylogous acid derivatives